Jiangsu Only Three Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Jul 16, 2025
Est. Valuation
$84.21M
Total Funding Raised
$33.47M
Company Overview
Jiangsu Only Three Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was an Early Funding round in July 2025.
Jiangsu Only Three Biotechnology Co., Ltd. is a synthetic biotechnology company that specializes in the research, development, production, and sales of bioactive raw materials, particularly ergothioneine, for the health and beauty industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Only Three Biotechnology Co., Ltd. Comparables
Compare Jiangsu Only Three Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spec-Chem Industry Inc. | 83% | |
| Shanghai EGT Synbio Group Co., Ltd. | 82% | |
| Wuhan Hesheng Technology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Jiangsu Only Three Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 16, 2025 | ||||
| Early Funding | Apr 3, 2025 | ||||
| Angel | Jul 28, 2023 |
For institutional investors. Book with your work email.
Jiangsu Only Three Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huayi Capital | Early Funding |
| JAFCO Asia | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
$10M raised from Tuoxin Pharmaceutical Group
- Apr 3, 2025
$15M raised with JAFCO Asia leading the round.
For institutional investors. Book with your work email.
Jiangsu Only Three Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jiangsu Only Three Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Only Three Biotechnology Co., Ltd. a public or private company?
Jiangsu Only Three Biotechnology Co., Ltd. is a private company.
What is the current stock price of Jiangsu Only Three Biotechnology Co., Ltd.?
Jiangsu Only Three Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Jiangsu Only Three Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jiangsu Only Three Biotechnology Co., Ltd. worth (valuation)?
Jiangsu Only Three Biotechnology Co., Ltd.'s valuation is estimated at $84.2M based on funding round data.
Can I buy Jiangsu Only Three Biotechnology Co., Ltd. stock?
Jiangsu Only Three Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jiangsu Only Three Biotechnology Co., Ltd.'s last funding round?
Jiangsu Only Three Biotechnology Co., Ltd.'s most recent funding round was Early Funding on July 16, 2025.
Who are the main investors in Jiangsu Only Three Biotechnology Co., Ltd.?
Key investors in Jiangsu Only Three Biotechnology Co., Ltd. include JAFCO Asia.
Will Jiangsu Only Three Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu Only Three Biotechnology Co., Ltd..
How can I track Jiangsu Only Three Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Jiangsu Only Three Biotechnology Co., Ltd.'s shares on secondary markets.